| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma (NCT05116800) | Brown University | 2022-03-01 |
| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone (NCT05033288) | Mayo Clinic | 2022-01-20 |
| Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance (NCT06202599) | Peking University People's Hospital | 2021-11-25 |
| Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients (NCT05051059) | Universitaire Ziekenhuizen KU Leuven | 2021-10-01 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas (NCT04906876) | Brown University | 2021-09-01 |
| Exercise Intervention for Bone Tumor Patients (NCT04963517) | Universität Duisburg-Essen | 2021-08-07 |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients (NCT04698785) | Centre Leon Berard | 2021-07-21 |
| Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas (NCT06669013) | N.N. Petrov National Medical Research Center of Oncology | 2021-05-20 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) (NCT04634227) | University of Iowa | 2020-11-24 |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (NCT04055220) | Centre Leon Berard | 2020-03-03 |
| Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK (NCT04181970) | Grupo Espanol de Investigacion en Sarcomas | 2019-06-30 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (NCT03468075) | Mohammed Milhem, MBBS | 2018-07-11 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas (NCT03442465) | Memorial Sloan Kettering Cancer Center | 2018-02-14 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (NCT03277924) | Grupo Espanol de Investigacion en Sarcomas | 2017-05-31 |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma (NCT02520128) | University College, London | 2016-03-01 |
| In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma (NCT02811523) | University Health Network, Toronto | 2016-02-01 |
| SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas (NCT02301039) | Sarcoma Alliance for Research through Collaboration | 2015-03-01 |
| Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma (NCT02384473) | University of Southern California | 2014-12-24 |
| Dendritic Cell Vaccine for Children and Adults With Sarcoma (NCT01803152) | Macarena De La Fuente, MD | 2014-01-06 |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI (NCT01336803) | Heike E Daldrup-Link | 2011-08-01 |
| Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NCT00592293) | Massachusetts General Hospital | 2006-10-24 |
| Dalteparin in Preventing DVT in Participants With Cancer (NCT00525057) | M.D. Anderson Cancer Center | 2006-07-07 |